CORDIS
EU research results

CORDIS

English EN

Mastering hospital antimicrobial resistance and its spread into the community

Project information

Grant agreement ID: 37941

  • Start date

    1 February 2007

  • End date

    31 July 2012

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 12 567 220

  • EU contribution

    € 10 000 000

Coordinated by:

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France

Objective

Infections caused by antimicrobial-resistant bacteria (AMRB) account for an increasing proportion of healthcare-associated infections, particularly in high-risk units such as intensive care units and surgery; patients discharged to rehabilitation units often remain carriers of AMRB, contributing to their dissemination into longer-term care areas and within the community.

The overall objective of MOSAR is to gain breakthrough knowledge in the dynamics of transmission of AMRB, and address highly controversial issues by testing strategies to combat the emergence and spread of antimicrobial resistance, focusing on the major and emerging multi-drug antimicrobial resistant microorganisms in hospitals, now spreading into the community. Microbial genomics and human response to carriage of AMRB will be integrated with health sciences research, including interventional controlled studies in diverse hospital settings, mathematical modelling of resistance dynamics, and health economics.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

Address

2 Rue D'Alesia, Cs 51419,
Paris

France

Participants (16)

UNIVERSITEIT ANTWERPEN

Belgium

NATIONAL MEDICINES INSTITUTE

Poland

INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

Spain

UNIVERSITY MEDICAL CENTER UTRECHT

Netherlands

THE MEDICAL RESEARCH, INFRASTRUCTURE AND HEALTH SERVICES FUND OF THE TEL-AVIV MEDICAL CENTER

Israel

HEALTH PROTECTION AGENCY

United Kingdom

UNIVERSITE PARIS 12 VAL DE MARNE

France

INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE

France

INSTITUT PASTEUR

France

INSERM-TRANSFERT SA

France

INGEN BIOSCIENCES

France

BAG HEALTH CARE GMBH

Germany

BRITISH BIOCELL INTERNATIONAL LIMITED

United Kingdom

AMPTEC GMBH

Germany

ARRAY-ON GMBH

Germany

UNIVERSITE DE GENEVE

Switzerland

Project information

Grant agreement ID: 37941

  • Start date

    1 February 2007

  • End date

    31 July 2012

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 12 567 220

  • EU contribution

    € 10 000 000

Coordinated by:

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE

France